American Journal of Neuroradiology 27:1794-1798, September 2006
© 2006 American Society of Neuroradiology
BRAIN
Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis?
a Department of Radiology/Neuroradiology, University Hospital of Bonn, Bonn, Germany
b Department of Neurology, University Hospital of Bonn, Bonn, Germany
Please address correspondence to Mike Peter Wattjes, MD, Department of Radiology and Neuroradiology, University Hospital of Bonn, Sigmund-Freud-Str 25, D-53105 Bonn, Germany; e-mail: mike.wattjes{at}ukb.uni-bonn.de
BACKGROUND AND PURPOSE: Current MR imaging criteria for multiple sclerosis (MS) do not specify the magnetic field strength. The aim of this study was to investigate whether different MR imaging field strengths, specifically high-field MR imaging, have an impact on the classification of patients with clinically isolated syndromes suggestive of MS, according to MR imaging and diagnostic criteria.
METHODS: In a prospective intraindividual comparative study, we examined 40 patients with clinically isolated syndromes (CIS) consecutively with a 1.5T and 3T MR imaging system, including axial sections of T2 turbo spin-echo, fluid-attenuated inversion recovery, and T1 spin-echo, before and after injection of gadolinium-diethylene-triaminepentaacetic acid. Constant resolution parameters were used for both field strengths. High-signal-intensity white matter lesions with a size of >3 mm were counted and categorized according to their anatomic location in infratentorial, callosal, juxtacortical, periventricular, and other white matter areas. Assessment of the fulfilled Barkhof MR imaging and McDonald diagnostic criteria was made separately for both field strengths in every patient.
RESULTS: Eleven patients fulfilled more MR imaging criteria at 3T. Two of these patients fulfilled the criterion of dissemination in space (DIS) according to the first definition of McDonald criteria, which is based on imaging criteria alone. Another patient had DIS only at 3T, according to the second definition of the McDonald criteria including CSF parameters.
CONCLUSION: MR field strength, specifically high-field MR imaging, has a substantial influence on the classification of patients with CIS according to imaging and a mild influence on the classification according diagnostic criteria for MS, leading to consequences for prognostic classification, imaging guidelines, and clinical trials.
This article has been cited by other articles:
 |
|
 |
|
  F. Aboul-Enein, M. Krssak, R. Hoftberger, D. Prayer, and W. Kristoferitsch Diffuse White Matter Damage Is Absent in Neuromyelitis Optica AJNR Am. J. Neuroradiol., January 1, 2010; 31(1): 76 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Neema, Z.D. Guss, J.M. Stankiewicz, A. Arora, B.C. Healy, and R. Bakshi Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 911 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Kuhl, F. Traber, and H. H. Schild Whole-Body High-Field-Strength (3.0-T) MR Imaging in Clinical Practice * Part I. Technical Considerations and Clinical Applications Radiology, March 1, 2008; 246(3): 675 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Lutterbey, M P Wattjes, J Kandyba, M Harzheim, M V Falkenhausen, N Morakkabati, H Schild, and J Gieseke Clinical evaluation of a speed optimized T2 weighted fast spin echo sequence at 3.0 T using variable flip angle refocusing, half-Fourier acquisition and parallel imaging Br. J. Radiol., August 1, 2007; 80(956): 668 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zivadinov Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology, May 29, 2007; 68(22_suppl_3): S72 - S82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P. Wattjes, G.G. Lutterbey, J. Gieseke, F. Traber, L. Klotz, S. Schmidt, and H.H. Schild Double Inversion Recovery Brain Imaging at 3T: Diagnostic Value in the Detection of Multiple Sclerosis Lesions AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 54 - 59. [Abstract] [Full Text] [PDF]
|
|